Latest news for Kelyniam Global (OTC:KLYG) Stock

Kelyniam Global Inc engaged in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures.

News

KLYG

KLYG Receives FDA Clearance To Market Cranial Implant (KLYG)

KELYNIAM GLOBAL INC by Kelyniam Global, Inc.

Kelyniam Global Inc

<p>Kelyniam Global (KLYG) an emerging medical device manufacturer, announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Patient Specific Custom Cranial Implants.  </p>

Kelyniam Global posts revenue of $1.1M for six months ended June 30

Kelyniam Global reports FY results

Kelyniam Global reports Q1 results

Earnings

Small Cap

Press Releases

Kelyniam Global Releases 2nd Quarter 2023 Financials

Kelyniam Global Releases 3rd Quarter 2023 Financials

Strong Fourth Quarter Powers 2023 Kelyniam Financials

NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use

Kelyniam Global Releases Q1 Financials

Kelyniam Global

Intraday Update

Markets

Movers

Trading Ideas

AAGC

AAGIY

AAWC

ABCE

ABNAF

ABVC

ACAM

ACCA

ACCR

ACMC

ACRFF

AERG

AERO

AFPW

AGFAF

AGHI

AGLDF

AHELF

AINSF

AIRT

ALAN

ALPE

ALPP

ALST

AMBS

AMHPF

AMMX

AMPG

ANTH

ANXGF

APAFF

APHD

APNHY

ARAFF

AREB

ARRRF

ARYC

ARZTY

ASNT

ATDS

ATHOF

AUOTY

AVBH

AVOI

AVVH

AXTG

BABB

BANJ

BAYK

BBAVY

BBKCF

BBRRF

BCCI

BCCLF

BDVB

BEPTF

BIOIF

BIPH

BIXT

BKIRF

BKRKF

BKRKY

BLAGF

BLIAQ

BMRK

BNCC

BOLYY

BONTQ

BOTJ

BREUF

BRGGF

BRLXF

BRPHF

BRUZF

BRYN

BRZL

BSCA

BSGC

BTTR

BXNG

BXRX

BYOC

CALB

CAWW

CBAN

CBAT

CBDL

CBMJ

CBYAA

CCCGY

CCLAF

CCOHY

CDTI

CDUAF

CELZ

CESDF

CGNH

CGOL

Stocks That Hit 52-Week Lows On Tuesday

Kelyniam Global (KLYG) an emerging medical device manufacturer, announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Patient Specific Custom Cranial Implants.  

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Kelyniam Global

News

Latest news for Kelyniam Global (OTC:KLYG) Stock

Tuesday, March 24, 2020

Wednesday, April 20, 2011